Zura Bio Ltd (NASDAQ: ZURA) on Tuesday, soared 9.09% from the previous trading day, before settling in for the closing price of $1.1. Within the past 52 weeks, ZURA’s price has moved between $0.97 and $5.07.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of -25.83%. With a float of $38.63 million, this company’s outstanding shares have now reached $68.37 million.
Let’s determine the extent of company efficiency that accounts for 30 employees. In terms of profitability, gross margin is 0.0%, operating margin of -3303200.0%, and the pretax margin is -3104900.0%.
Zura Bio Ltd (ZURA) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Zura Bio Ltd is 37.57%, while institutional ownership is 60.97%. The most recent insider transaction that took place on Nov 25 ’24, was worth 2,734,458. In this transaction Director of this company sold 1,001,633 shares at a rate of $2.73, taking the stock ownership to the 0 shares. Before that another transaction happened on Sep 11 ’24, when Company’s Director sold 3,800,000 for $2.70, making the entire transaction worth $10,260,000. This insider now owns 1,001,633 shares in total.
Zura Bio Ltd (ZURA) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -25.83% per share during the next fiscal year.
Zura Bio Ltd (NASDAQ: ZURA) Trading Performance Indicators
Zura Bio Ltd (ZURA) is currently performing well based on its current performance indicators. A quick ratio of 8.14 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.76, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -0.80 in one year’s time.
Technical Analysis of Zura Bio Ltd (ZURA)
Looking closely at Zura Bio Ltd (NASDAQ: ZURA), its last 5-days average volume was 0.39 million, which is a drop from its year-to-date volume of 0.45 million. As of the previous 9 days, the stock’s Stochastic %D was 63.78%.
During the past 100 days, Zura Bio Ltd’s (ZURA) raw stochastic average was set at 32.37%, which indicates a significant decrease from 86.81% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0878 in the past 14 days, which was lower than the 0.1190 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.1806, while its 200-day Moving Average is $2.1969. However, in the short run, Zura Bio Ltd’s stock first resistance to watch stands at $1.2601. Second resistance stands at $1.3203. The third major resistance level sits at $1.4101. If the price goes on to break the first support level at $1.1101, it is likely to go to the next support level at $1.0203. Now, if the price goes above the second support level, the third support stands at $0.9601.
Zura Bio Ltd (NASDAQ: ZURA) Key Stats
Market capitalization of the company is 74.25 million based on 68,375K outstanding shares. Right now, sales total 0 K and income totals -45,390 K. The company made 0 K in profit during its latest quarter, and -17,440 K in sales during its previous quarter.
